"name","uuid:ID","label","id","text","description","instanceType"
"OBJ1","c1730181-9460-41b3-a54c-febe0c0c4438","","Objective_1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Main objective","Objective"
"OBJ2","dd40a112-95ba-400d-aca9-6ec5c9067078","","Objective_2","To document the safety profile of the xanomeline TTS.","Safety","Objective"
"OBJ3","c1d98a3d-4039-4efe-8957-36e604677d25","","Objective_3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Behaviour","Objective"
